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1. ABSTRACT 
Helicobacter pylori has been established as a primary cause of gastritis and of peptic ulcers in 
humans. It has also been recognized as a major risk factor for mucosa-associated lymphoid 
tissue (MALT) lymphoma and adenocarcinoma. Besides H. pylori, other Helicobacter 
species with long tightly coiled spiral bacteria have been rarely identified in patients with 
gastritis (in 0.2% to 6% of individuals who present with upper gastrointestinal symptoms) 
and with MALT lymphoma. These non-H. pylori gastric Helicobacter species (NPGHS) have 
been classified as H. heilmannii sensu lato (s. l.) and currently include a total of seven species. 
At present, H. bizzozeronii and H. felis are the only H. heilmannii s. l. species that have been 
successfully cultivated from human gastric biopsies. In contrast to human-to-human 
transmission described for H. pylori, the H. heilmannii s. l. are transmitted from animals to 
humans (zoonotic). To date, an understanding of the pathogenesis of non-pylori Helicobacter 
infections in humans and also of the mechanisms of their adaptation are lacking. In order to 
provide new insights into these topics, the present study focused on the molecular biology of 
H. bizzozeronii with particular interest in unravelling the bacterial features involved in host-
jumping and adaptation to the human gastric mucosa. The study also investigated the 
molecular mechanisms of metronidazole resistance in H. bizzozeronii.  
 
This thesis consists of four parts. A comparative genome analysis between H. pylori and a 
human isolate of H. bizzozeronii CIII-1 was performed in study I. In that study we 
investigated several molecular genetic features that could explain the zoonotic nature of 
NPGHS. In particular, we hypothesized that the high metabolic versatility, in terms of energy 
sources and the electron transport chain, and the ability to react to a range of environmental 
signals, mediated by higher numbers of methyl-accepting chemotaxis proteins, were the key 
factors that differentiate H. bizzozeronii and other species belonging to H. heilmannii s. l. 
from H. pylori. This finding might form the molecular basis of the zoonotic transmission 
capability of H. bizzozeronii between dogs and humans. 
 
In study II, the biosynthesis of lipopolysaccharide (LPS) of H. bizzozeronii has been 
investigated. As a major Gram-negative cell surface component, LPS has the potential to 
interact with certain surface components of the host’s cells during infection, which modifies 
the inflammatory response and promotes progress of chronic infection. Our results showed 
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that H. bizzozeronii expresses sialyl-LPS (containing the sialyl-lactoseamine epitope), which 
is a common characteristic among canine and human H. bizzozeronii strains. The expression 
of sialyl-glycans undergoes phase- and antigen variation and may influence the adaptation 
process of H. bizzozeronii during the transmission from dogs to humans. 
 
Like H. pylori, H. heilmanni s.l has been implicated in the pathogenesis of human gastritis. 
Metronidazole, in combination with other antibiotics, is frequently used for the eradication of 
H. pylori infections but resistance to this antibiotic is a serious, increasing problem and a 
major cause of treatment failure. H. heilmannii s. l. have specific and peculiar growth 
requirements that makes difficult to isolate them as well to estimate their in vitro 
antimicrobial susceptibility. Therefore, knowledge of the optimal treatment regimen for H. 
heilmannii s. l. infections remains undefined and a conventional H. pylori eradication 
treatment is generally recommended. Indeed, the standard antimicrobial therapy used for H. 
pylori appears to eradicate H. heilmannii s. l. infection in most patients. However, cases of 
failed treatment have been reported. At present, only limited information on the prevalence of 
antimicrobial resistance of H. heilmannii s. l. species is available. 
 
In study III, we performed comparative genomic analysis between antrum derived H. 
bizzozeronii populations that had been isolated from biopsy samples from a female Finnish 
patient who was suffering from chronic gastritis. The biopsies were taken three months 
before (T0) and six months after (T1) an unsuccessful eradication treatment. Study III showed 
that H. bizzozeronii had undergone genome diversification in order to colonize the patient’s 
stomach successfully. We hypothesised that antimicrobial treatment induced a sudden 
decrease of H. bizzozeronii population size but effectively favoured the selection of a 
subpopulation, which subsequently acted as the founder of a new population that was 
characterized by higher numbers of fixed mutations. H. bizzozeronii isolates obtained after 
the treatment underwent a frame length extension of the oxygen-insensitive NAD(P)H-
nitroreductase HBZC1_00960 (homologue of H. pylori RdxA) that is associated with the 
disruption of the C-terminal cysteine-containing conserved region (IACLXALGK). This 
disruption was the result of the extension (from C8 to C9) of a simple sequence cytosine 
repeat (SSCR) (homopolymeric tract) that is located in the 3 region of the rdxA gene.  
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Study IV showed that, in most of the in vitro spontaneous H. bizzozeronii metronidazole 
resistant mutants, the only observed mutation was that of the extension of the 3 SSCR of 
rdxA. Another major observation was that the MIC value of metronidazole for both 
spontaneous mutant isolates and an H. bizzozeronii ΔrdxA mutant strain were similar, which 
indicates that a loss of rdxA function is associated with the reduced susceptibility of H. 
bizzozeronii to metronidazole. Another key finding was that H. bizzozeronii acquires 
resistance to metronidazole at high mutation rates and that serial passages in vitro without 
selection induce reversibility of the resistant phenotype. These results suggest that the 
potential contingency nature of rdxA should be carefully considered if metronidazole is 
administered for the treatment of H. heilmannii-associated gastritis. 
 
The results of the present studies contribute substantially in the understanding of the zoonotic 
nature of non-H. pylori gastric Helicobacter species and of the molecular mechanisms behind 
successful colonization and acquired antimicrobial resistance. Further studies are required in 
order to elucidate the specific roles of characterized factors, such as polysaccharide lyase and 
Sialyl-LPS, in the development of gastritis and MALT lymphoma. 
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4. REVIEW OF LITERATURE  
4.1 Genus Helicobacter  
The genus Helicobacter belongs to the class Proteobacteria, in the order Campylobacterales, 
and the family Helicobacteraceae. To date, the genus Helicobacter comprises more than 32 
validated and described species (Haesebrouck, et al., 2009) and several unclassified taxa 
(Rossi & Hänninen, 2012).  
 
Helicobacter species are characterized as gram-negative, non-spore forming, curved, spiral or 
fusiform bacteria, which are coccoid in shape in old culture. They are typically 0.2 to 1μm in 
diameter and 1.5 to 10.0 μm long and harbour multiple sheathed flagella that have a polar or 
bipolar distribution (Solnick & Vandamme, 2001). In general, Helicobacter spp. grow under 
microaerophilic conditions at 37°C. Most of the species are catalase and oxidase positive. 
Further, many species are positive for urease and alkaline phosphatase (Solnick & 
Vandamme, 2001). 
 
Helicobacter spp. colonize the gastrointestinal tract, oral cavity and internal organs of 
humans and animals. Most of Helicobacter spp. are pathogenic and can be subdivided into 
two major groups, the gastric Helicobacter species and the enterohepatic (nongastric) 
Helicobacter species.  
 
4.2 Gastric Helicobacter species of humans and domestic animals 
Helicobacter spp. are highly diverse in nature, gastric Helicobacter species colonise the 
stomachs of mammals and the colonisation generally persists throughout the lifetime of their 
hosts (Atherton & Blaser, 2009, Haesebrouck, et al., 2009). H. pylori is a well known human 
associated gastric Helicobacter species. Analysis of geographically distinct H. pylori lineages 
have revealed that modern humans and H. pylori originated from common ancestors that 
lived together in Africa approximately 58 000 years ago, which suggests an intimate 
association between the bacterium and its human host population ever since (Linz, et al., 
2007). This observation, along with the fact that bacteria of the Helicobacter genus appear to 
have a species specific tropism (Rossi & Hänninen, 2012), led to the hypothesis that 
Helicobacter species co-evolved with their hosts during the emergence of mammals. Several 
species that belong to the group of H. heilmannii sensu lato (including H. bizzozeronii, H. 
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felis and H. suis), have zoonotic potential that enables them to transfer from animals to 
humans (Haesebrouck, et al., 2011, Roehrl, et al., 2012). The molecular mechanisms behind 
the zoonotic nature of these species are currently unknown and need to be studied to improve 
our knowledge of gastric Helicobacter infections in both humans and animals. 
  
4.2.1 Helicobacter pylori infections in humans 
In 1984, Barry Marshall and Robin Warren successfully isolated and cultured H. pylori from 
the human stomach. Later on, H. pylori was established as the primary cause of gastritis and 
peptic ulceration and has been determined as a major risk factor for mucosa-associated 
lymphoid tissue (MALT) lymphoma and adenocarcinoma (Kusters, et al., 2006). The 
prevalence of H. pylori infection shows large geographical variations and in general it is very 
high in developing countries (~80%). By contrast, the prevalence of H. pylori infection in 
industrialized countries is generally under 40% and is considerably lower in younger age 
groups than in older age groups (Kusters, et al., 2006). In Finland less than 10% of children 
harbour H. pylori, compared to 70-80% among persons 70 years of age or over (Rautelin & 
Kosunen, 2004). Acquisition of H. pylori mostly occurs in early childhood, which could most 
probably from another family member, and very seldom does it clear spontaneously. After 
the primary infection, the patient develops asymptomatic gastritis. In most cases, the 
Helicobacter infection is asymptomatic for the rest of the host’s life. However, about 10–20% 
of people carrying H. pylori will develop chronic gastrointestinal symptoms later on in their 
lives (Kusters, et al., 2006). 
 
4.2.2 Non-H. pylori gastric Helicobacter infections in humans and domestic animals. 
A minority of patients with upper gastrointestinal symptoms (0.2-6%) had long tightly coiled 
spiral bacteria in their gastric biopsies (Haesebrouck, et al., 2009). These non-H. pylori 
gastric Helicobacter species (NPGHS) were first described in 1987 (Dent, et al., 1987) and 
later they were provisionally named as “H. heilmannii”. In contrast to the human-human 
mode of transmission described for H. pylori, it has been suggested that “H. heilmannii" is 
transmitted by animals (zoonosis) (Meining, et al., 1998, Jalava, et al., 2001). Analysis of the 
16S rRNA gene sequences of “H. heilmannii” revealed the occurrence of at least two separate 
taxa, which were designated as “H. heilmannii” type one and two (Dewhirst, et al., 2005). 
Subsequent studies showed that the “H. heilmannii” type one belongs to H. suis, the gastric 
Helicobacter species that colonizes pigs, whereas “H. heilmannii” type two was shown to 
comprise H. felis, H. bizzozeronii, H. salomonis, H. cynogastricus and H. baculiformis all of 
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which are species that commonly colonize the gastric mucosa of pet cats and dogs 
(Haesebrouck, et al., 2011). Although the name H. heilmannii has been used for many years, 
it was not formally recognized as a valid species name until recently when H. heilmannii has 
been formally described from gastric samples of cats. To avoid further misunderstanding, the 
term “H. heilmannii sensu lato, (s. l.) ” which refers to the whole group of NPGHS detected 
in the human or animal stomach has been introduced. In addition, the term H. heilmannii 
sensu stricto has also been introduced to specifically identify it at the species level 
(Haesebrouck, et al., 2011, Smet, et al., 2012).  
 
Several groups have unsuccessfully attempted to recover H. heilmannii s. l. from human 
gastric biopsies in vitro.  H. bizzozeronii (Jalava, et al., 2001, Kivistö, et al., 2010) and H. 
felis (Wuppenhorst, et al., 2013) are the only NPGHS that have been isolated and 
successfully cultivated from human gastric samples to date.  
 
As in the case of H. pylori, H. heilmannii s l. has also been implicated in the pathogenesis of 
human gastritis (Ierardi, et al., 2001, Joo, et al., 2007). Gastritis associated with H. 
heilmannii s l. is usually mild to moderate, with mild inflammatory activity and less foveolar 
epithelial damage compared to those found for the H. pylori infections. Direct invasion of the 
parietal cells by H. heilmannii s. l. accompanied by erosive gastritis is a rare occurrence. 
Occasionally H. heilmannii s. l. might adhere to epithelial cells that could be related to mild 
neutrophilic infiltration (Ierardi, et al., 2001, Joo, et al., 2007). Severe complications of H. 
heilmannii s. l. infection, such as MALT lymphoma (Okiyama, et al., 2005) or gastric 
adenocarcinoma have been reported. Moreover, it is noteworthy that the occurrence of 
MALT lymphoma seems to be more frequent among patients infected by H. heilmannii s. l. 
compared to those infected by H. pylori (Parsonnet, et al., 1991). Acute or chronic epigastric 
pain and nausea are normal symptoms for NPGHS infected people. Other non-specific 
symptoms are: hematemesis, vomiting, recurrent dyspepsia, irregular defecation frequency 
and consistency, heartburn and dysphagia, often accompanied by a decreased appetite 
(Haesebrouck, et al., 2009). Some people infected with NPGHS do not experience any clear 
clinical symptoms or manifest any signs (Mazzucchelli, et al., 1993).  
 
Gastric Helicobacter species that belong to H. heilmannii s. l. type 2 are highly prevalent (60 
to 100%) in dogs and cats with or without dyspeptic symptoms (Jalava, et al., 1998, Neiger & 
Simpson, 2000). The most prevalent gastric Helicobacter species that have been isolated 
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from dogs are H. bizzozeronii, H. salomonis, whereas from cats it is H. felis. Studies have 
also revealed the presence of H. felis in dogs but H. bizzozeronii and H. salomonis have never 
been detected in cats, which suggests that dogs are the primary source for H. bizzozeronii in 
human infection cases (Bridgeford, et al., 2008). In dogs with natural Helicobacter infection, 
mild gastritis with infiltration of the lymphocytes and plasma cells has been commonly 
observed (Happonen, et al., 1998, Neiger & Simpson, 2000). Histological findings in 
Helicobacter infected cats vary from a normal gastric mucosa to mild or moderate chronic 
gastritis (Happonen, et al., 1998, Neiger & Simpson, 2000). Severe gastric inflammation and 
gastric lymphoma have rarely been reported (Harbour & Sutton, 2008).  
 
4.3 Transmission of non-H. pylori gastric Helicobacter species 
Data on NPGHS infections in human and the associated mechanisms for their zoonotic 
transmissions are not well studied (Haesebrouck, et al., 2009). It is of primary importance to 
trace NPGHS in the gastric mucosa of humans and animals it will allow us to understand 
better their zoonotic nature. Several studies in Belgium have shown that, H. suis comprises 
between 13.9% to 30.9% of human NPGHS infections (De Groote, et al., 2005, Van den 
Bulck, et al., 2005a, Van den Bulck, et al., 2005b). The results of a questionnaire-based study 
suggested that pigs are the main source of H. suis infections in humans (Meining, et al., 
1998), whereas dogs and cats may serve as a source of H. bizzozeronii, H. felis, H. heilmannii 
s. l. and H. salomonis infections in humans. So far, other species such as H. baculiformis and 
H. cynogastricus have not been detected in the human stomach (Haesebrouck, et al., 2009).  
 
It has been proposed that the transmission of H. salomonis from the dam to her puppies occur 
through the oral-oral or gastric-oral contact (Hänninen, et al., 1998) or for H. mustelae 
mainly through the faecal-oral transmission route (Fox, et al., 1992). In general, it seems that 
faecal-oral transmission is less important than the oral-oral or the gastric-oral contact 
(Haesebrouck, et al., 2009). Living in close contact with pet animals such as cats and dogs 
has been identified as a risk factor for the zoonotic transmission of these species to humans 
(Holck, et al., 1997, Meining, et al., 1998, Svec, et al., 2000). Therefore, direct contact 
appears to be the main transmission route from animals to humans. However, recent data 
revealed the ability of H. suis to survive in the pig carcass at the slaughterhouse, and this 
finding also suggests a possible role of the food chain in the transmission of H. heilmannii s. l. 
(De Cooman, et al., 2012). 
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4.4 Diagnostics and identification of non-H. pylori gastric Helicobacter species. 
Several methods have been used for the detection of gastric Helicobacter species. Invasive 
methods include histological, culture and urease tests of the gastric specimen whereas non-
invasive methods include urea in the breath, faecal antigen and serological tests (Kusters, et 
al., 2006). Due to the fastidious nature of NPGHS, only a few laboratories have succeeded in 
isolating these species from the gastric biopsies taken from animals or from humans. Hence, 
cultivation is not the best diagnostic approach to take. Microscopic detection is the most 
widely used method and usually allows differentiation between H. pylori and the NPGHS 
(Baele, et al., 2009). However, under some microscopy conditions, H. pylori could appear to 
be similar to NPGHS, which would adversely affect the correct diagnosis (Fawcett, et al., 
1999). Although some morphological features could be used to differentiate between species 
among the NPGHS, their morphological features are often indistinguishable under 
conventional light microscopy (Stoffel, et al., 2000, Baele, et al., 2009). Thus, microscopical 
investigation of biopsy samples per se is not robust enough for accurate species identification 
of H. heilmannii s. l. (Baele, et al., 2009). PCR followed by sequencing is the most optimum 
method for identification of these species (Baele, et al., 2009). 16S rRNA and 23S rRNA 
genes can be used for distinguishing H. suis from other non-pylori gastric Helicobacter 
species. However, these genes cannot be used for distinguishing between H. felis, H. 
bizzozeronii, H. salomonis and H. heilmannii s. s. (sensu stricto ) due to the high sequence 
similarities between them (Dewhirst, et al., 2005, Van den Bulck, et al., 2006). H. felis, H. 
bizzozeronii, H. salomonis and H. heilmannii s. s. can be successfully differentiated by ureAB 
(Neiger, et al., 1998, O'Rourke, et al., 2004), hsp60 (Mikkonen, et al., 2004) and gyrB gens 
(Hannula & Hänninen, 2007). 
Several serological tests have been developed for the diagnosis of H. pylori infections. To the 
best of our knowledge, only one serological method has been described for the diagnosis of 
gastric Helicobacter species in dogs (Strauss-Ayali, et al., 1999). However, no antibodies are 
available for the diagnosis of NPGHS in humans (Baele, et al., 2009). 
4.5 Treatment of non-H. pylori gastric Helicobacter species  
A combination of proton pump inhibitors and two antimicrobial agents (selected from 
clarithomycin, metronidazole, amoxicillin, and tetracycline) are used for the treatment of 
gastric Helicobacter infections in both humans and animals. (Goddard, et al., 1997, 
Kaklikkaya, et al., 2002, Sykora, et al., 2003, Haesebrouck, et al., 2009). However, antibiotic 
resistance could lead to failure of the treatment. The frequency of antibiotic resistance in 
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these species in different hosts is not well known because of the difficulty of cultivating 
NPGHS caused by their fastidious nature. The antimicrobial susceptibility of some strains of 
different NPGHS that were successfully isolated from animals has been studied (Van den 
Bulck, et al., 2005a, Vermoote, et al., 2011b). These studies showed that acquired resistance 
of NPGHS to several antibiotics, including tetracycline, fluoroquinolones and metronidazole 
may occur (Van den Bulck, et al., 2005a, Vermoote, et al., 2011b). Molecular mechanisms of 
antimicrobial resistance to fluoroquinolones were further investigated in H. suis (Vermoote, 
et al., 2011b). However, studies that investigate the molecular mechanisms involved in the 
resistance to other antibiotics, such as metronidazole are still not available. Metronidazole in 
combination with other antibiotics is usually used as the first choice of treatment against H. 
pylori infections (Rimbara, et al., 2011). Increasing occurrences of resistant strains in the last 
few years (Kupcinskas, et al., 2012) have been reported.  The current rates of resistant strains 
vary from 17% in Europe to 44% in America (Wu, et al., 2012). The acquisition of resistance 
by H. pylori is highly associated with mutational inactivation of the rdxA gene, which 
encodes for an oxygen-insensitive NADPH nitroreductase (Goodwin, et al., 1998, Kwon, et 
al., 2000). Another study found that the inactivation of frxA (NADPH flavin oxidoreductase), 
fdxB (ferredoxin-like protein) and possibly other reductase-encoding genes may also 
contribute to NPGHS acquiring metronidazole resistance (Jenks & Edwards, 2002).  
4.6 Genome sequence of non-H. pylori gastric Helicobacter species 
Several genome sequences of H. pylori are available as are the genomes of some other gastric 
Helicobacter species, which were also published. Among H. heilmannii s. l., the genomes of 
the type strain H. felis (Arnold, et al., 2011) isolated from the cat, two strains of H. suis 
(Vermoote, et al., 2011) both isolated from pigs, and the type strain of H. heilmannii s. s., 
isolated from the cat (Smet, et al., 2013) were sequenced and analysed. The respective size of 
the chromosomes of these species are similar (ranged between 1.6 to 1.8Mb) and the GC 
content has been reported to range between 40 and 47% (Arnold, et al., 2011, Vermoote, et 
al., 2011, Smet, et al., 2013). H. felis, H. suis and H. heilmannii s. s.  share the majority of 
their genes and most of the virulence factors with H. pylori but lack CagA and VacA. They 
also share numerous features with other Helicobacter species that facilitate the colonization 
of the acidic environment of the stomach and which are also required for motility and 
chemotaxis (Arnold, et al., 2011, Vermoote, et al., 2011, Smet, et al., 2013). 
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4.7 Pathogenesis of non-H. pylori gastric Helicobacter infections. 
Pathogenesis of NPGHS is not well known compared to that of H. pylori. In contrast to H. 
pylori, NPGHS are not only able to colonise humans they also colonize a wide range of other 
hosts, which indicates that these species may use both similar virulence mechanisms as 
described in H. pylori but also other that may characterize their host-association (Kusters, et 
al., 2006, Haesebrouck, et al., 2009).  
All gastric Helicobacter spp. have to be able to cope with the highly acidic environment of 
the stomach in order to be successful in colonizing and living in the host’s stomach. 
Therefore, the most important colonization factor in gastric Helicobacter species is urease. 
Urease is an enzyme that consists of UreA and UreB subunits, that hydrolyzes urea into 
ammonia and carbon dioxide, neutralizes the hydrochloric acid of the stomach and generates 
a neutral colonization environment (Clyne, et al., 1995). Clusters of seven genes 
(ureABIEFGH) are required to produce active urease enzyme (Cussac, et al., 1992). All 
NPGHS are positive for urease but the specific role of this enzyme in these species is not well 
known. A second urease system UreA2B2 was detected in H. mustelae and H. felis and it 
showed high homology with the H. pylori urease system but the role of this enzyme in 
Table A: Comparison of Colonization, Motility, Chemotaxis, Natural Competence, and Virulence genes between H. pylori and 
three non-H. pylori gastric Helicobacter species. 
Trait  H. pylori  H. felis  H. suis H. heilmannii s.s 
Cag Pathogenic Island 
(CagPAI) 
Present Absent Absent Absent 
Type IV secretion ComB system ComB system  ComB system ComB system 
Urease production UreABIEFGH  
 
UreABIEFGH  
UreA2B2  
UreABIEFGH UreABIEFGH 
Vacuolating cytotoxin 
(VacA) 
Present Absent Absent Absent 
Neutrophil activation  
(NapA) 
Present Present Present Present 
Gamma-glutamy 
Transpeptidase (GGT) 
Present Present Present Present 
Outer membrane 
proteins 
Hop, Hor, Hof, 
Hom 
(including BabA, 
BabB, SabA, SabB) 
Hop, Hor, Hof, Hom 
(Absent  BabA, BabB, 
SabA, SabB) 
HpaA, Hop, Hor, Hof, 
Hom 
(Absent  BabA, BabB, 
SabA, SabB) 
Hop, Hor, Hof, Hom 
(Absent  BabA, BabB, 
SabA, SabB) 
Secreted serine 
protease 
(HtrA) 
Present Present Present Present 
Cytolethal distending 
toxin 
Absent  Absent Absent Absent 
DNA repair 
recombination 
recA, addA, addB recA, recN, addB, mutS recA, mutS recA, mutS 
Collagenase Present Present Present Present 
References Arnold et al., 2011 Arnold et al., 2011 Vermoote et al., 2011 Smet et al., 2013 
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colonization of these two species is currently unknown (Dunn, et al., 1991, Ferrero & 
Labigne, 1993, Pot, et al., 2007). UreA2B2 is an oxygen-labile urease, which is up-regulated 
in the presence of iron and down-regulated in the presence of nickel (Carter, et al., 2011). 
The fact that these species contain both nickel (UreAB) and iron-containing urease (UreA2B2) 
may be a consequence of coevolution with their natural host. The complete urease gene 
cluster of H. bizzozeronii has been sequenced and this urease is highly homologous with 
those of H. felis and H. pylori (Zhu, et al., 2002). 
 
Motility is a necessary mechanism for the successful colonization of the stomach by 
Helicobacter species. Motility enables gastric Helicobacter species to move toward the 
gastric mucosa (Josenhans, et al., 1999, Ottemann & Lowenthal, 2002). The possession of 
flagella is the main key factor in the motility of gastric Helicobacter species. It consists of a 
basal body, a hook and flagellar filament and is covered by a sheath. The basal body of the 
flagella is embedded into the bacterial cell wall and contains the proteins required for rotation 
and chemotaxis. The hook links the body and the filament. The flagellar filament is 
composed of FlaA and FlaB subunits, both of which are required for complete motility in 
vitro and in vivo (Josenhans, et al., 1995). The sheath is suspected to play a role in protection 
against acid, to mask antigens and possibly facilitate adhesion to the gastric mucosa (Jones, et 
al., 1997). As in the case of H. pylori, the flagella of H. mustelae is composed of the two 
flagellin subunits FlaA and FlaB, both subunits are shown to be necessary for the complete 
motility and colonization by H. mustelae in the ferret stomach (Josenhans, et al., 1995, 
Andrutis, et al., 1997). The flagellar structure and its role in the motility of H. felis is also 
described (Josenhans, et al., 1999). Isogenic flaA mutants of H. felis are unable to colonize 
the gastric mucosa of the mouse (Josenhans, et al., 1999). pH-tactic behaviour is another 
required mechanism for the successful colonization of the stomach. H. pylori displays pH-
tactic behaviour to escape from the highly acidic environment of the stomach by using the 
chemotaxis receptor TlpB (Croxen, et al., 2006).  
 
It is well known that H. pylori has direct or indirect contact with the host by its surface 
molecule, which modify the host’s immune system and thereby facilitate the infection of the 
host by this bacterium (Kusters, et al., 2006). The characterized surface molecules of H. 
pylori are the following: Blood group antigen-binding adhesin A (BabA), sialic acid binding 
adhesin (SabA), adherence-associated lipoprotein A and B (AlpA and AlpB), heat shock 
proteins (Hsps), extracellular & secreted proteins and lipopolysaccharide (LPS) (Bumann, et 
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al., 2002, Odenbreit, 2005, Kusters, et al., 2006). Natural and experimentally induced 
infections have shown that NPGHS also interact intimately with the gastric mucosa of the 
host (De Bock, et al., 2006, Lanzoni, et al., 2011), which indicates that these species utilize 
their surface molecules in order to evade the host’s immune system and establish persistent 
colonization. However, comparative genomics indicates the absence of the homologues of H. 
pylori adhesins such as BabA and SabA, which suggests the presence of different 
mechanisms.  
 
Few data are available on the pathogenesis of H. bizzozeronii. The ability of canine H. 
bizzozeronii strains to colonize and to cause diseases in laboratory animal models was 
compared with that of H. felis (De Bock, et al., 2006). The results indicated that H. 
bizzozeronii was far less pathogenic than H. felis for both mice and Mongolian gerbil models 
as it only produced a mild chronic active inflammation (De Bock, et al., 2006). Moreover, H. 
bizzozeronii did not adhere to gerbil gastric epithelial cells nor did NF-κB activation 
expression occur in contrast to that found for H. felis. However, NF-κB activation can be 
induced by mechanisms other than bacterial adherence. In recent studies, H. bizzozeronii was 
found in the intracellular canaliculi and in the cytoplasm of the parietal cells of the canine 
gastric mucosa and it is not clear how Helicobacter species penetrate and invade the 
cytoplasm of parietal cells (Lanzoni, et al., 2011). 
 
4.8 Isolation and characterization of H. bizzozeronii from a Finnish patient.  
In 1996, H. bizzozeronii was isolated for the first time from a human gastric biopsy that was 
taken from a Danish patient who was suffering from gastritis (Andersen, et al., 1996). In 
2008, H. bizzozeronii was isolated in gastric biopsies obtained from a 45 year-old Finnish 
female patient with severe dyspeptic symptoms, and who was negative for H. pylori. In 
March 2008, routine histological samples from antrum and corpus biopsies revealed chronic 
active gastritis and the presence of large spiral bacteria, corresponding to a H. heilmannii s. l. 
infection. Gram-negative organisms were isolated in almost all the gastric biopsies taken 
from the patient and identified as H. bizzozeronii. The symptoms subsided after triple therapy 
consisting of the administration of metronidazole, tetracycline, and lansoprazole for one week. 
However, the patient continued to suffer from mild nausea associated with eating warm foods 
and in a follow-up examination in November 2008, H. bizzozeronii was also isolated from the 
antrum biopsy samples. The Amplified Fragment Length Polymorphism (AFLP) typing 
method was used to analyse the genetic diversity among the 17 isolates obtained before and 
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after the failed treatment, and the results indicated that the isolates belonged to the same 
clone (Kivistö, et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
5. AIMS OF THE STUDY 
The main aim of thesis was to study the genetics of H. bizzozeronii with particular interest in 
identifying the bacterial features associated with the bacterium’s capability to transmit 
between canine and human hosts and to colonize human gastric mucosa. An additional aim 
was to understand the molecular mechanism behind the resistance to metronidazole acquired 
by H. bizzozeronii. The specific aims of each of the four parts of this thesis are as follows: 
 
1.  to perform a comparative genomics analysis between a human-derived H. bizzozeronii 
strain and H. pylori in order to identify genes associated with the transmission from the 
primary canine host to the human; 
 
2. to characterize the biosynthesis of sialylated lipopolysaccharide in H. bizzozeronii in 
order to understand the factors involved in host adaptation; 
 
3. to study the microevolution of H. bizzozeronii in its colonization of the stomach of the 
human before and after a failed treatment; 
 
4. to investigate the role of the H. bizzozeronii oxygen-insensitive NAD(P)H-nitroreductase 
rdxA in the acquisition of metronidazole resistance.  
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6. MATERIALS AND METHODS 
A brief description of the methods used in this study are presented here. More detailed 
descriptions of the methods and analyses are given in the original papers (I-IV). 
6.1 Bacterial isolates and cultivations (I-IV) 
All Helicobacter strains were stored at –70°C in skimmed milk that contained 15 % glycerol. 
Helicobacter strains were routinely grown on Helicobacter Pylori (HP) (LabM, Ltd, 
Lancashire, UK) containing 5% bovine blood and Skirrow selective supplement (Oxoid, Ltd, 
Cambridge, UK) at 37ºC in a microaerobic atmosphere for 3 to 4 days. The bacterial isolates 
that were used in studies I-IV are listed in Table 1.  Helicobacter strains were cultivated in 
BHI-FBv [Brain Heart Infusion (BHI) (BD, Becton Dickinson and Co., Franklin Lakes, NJ) 
containing 10% of Fetal Bovine Serum (Gibco, Invitrogen, Carlsbad, CA), Skirrow selective 
supplement and Vitox supplement (Oxoid Ltd, Cambridge, UK)] with continuous shaking 
(150 rpm) at 37ºC in a jar with microaerobic atmosphere for RNA and LPS extraction for 24 
h and 48 h respectively.  
 
Campylobacter strains were cultured on Muller-Hinton agar with 5% of bovine blood at 37ºC 
in an incubator with a microaerobic atmosphere. E. coli strains were cultivated on Luria-
Bertani (LB) medium or 2X Yeast extract-tryptone (2YT) that was supplemented with 
ampicillin or chloramphenicol as required. 
 
6.2 DNA and RNA isolation, PCR and RT-PCR (I- IV) 
H. bizzozeronii strains were cultivated on HP plates as described above, bacterial masses of 
two to three plates were collected and DNA was extracted using the chloroform-phenol 
method as described earlier (Kivistö, et al., 2010). The genomic DNA for studies I and III 
was extracted using a ZR Fungal/Bacterial RNA MiniPrep Kit (Zymo Research Co, Irvie, CA. 
USA). Bacterial mass was collected from a 24 h broth culture and treated with RNAprotect 
Bacteria reagent (Qiagen GmbH, Hamburg, Germany) for RNA extraction. RNA was 
extracted using RNeasy mini kit (Qiagen) and treated with Turbo DNase (Applied 
Biosystems/Ambion, Austin, TX). 
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Table 1. Bacterial species used in this study 
Bacterial species Strain Study Reference or source 
Helicobacter species 
H. bizzozeronii CIII-1
ORG 
(h) Study III & IV  Kivistö et al., 2010 
 AII-2 (h) Study III Kivistö et al., 2010 
 AII-4 (h) Study III Kivistö et al., 2010 
 AI-3 (h) Study III Kivistö et al., 2010 
 IA-1 (h) Study III Kivistö et al., 2010 
 IA-2 (h) Study III Kivistö et al., 2010 
 IA-3 (h) Study III Kivistö et al., 2010 
 CIII-1
GEN 
(h) Study I to IV Kivistö et al., 2010, 
Schott et al., 2011. 
 CIII-1
GEN 
C1
 ∆ rdxA Study IV Study III 
 CIII-1
GEN 
C2
 ∆ rdxA Study IV Study III 
 CIII-1
GEN 
M1 to CIII-1
GEN 
M11
§
 Study IV Study III 
 Storkis
 
CCUG 35545
T 
(c) Study II & IV Jalava et al., 1998 
 Storkis
 
CCUG 35545
T S1∆ rdxA Study IV Study III 
 Storkis
 
CCUG 35545
T 
S2 ∆ rdxA Study IV Study III 
 14 CCUG 35546 (c) Study II Jalava et al., 1998 
 12a (c) Study II Jalava et al., 1998 
 Heydar (c) Study II Jalava et al., 1998 
 Yrjälä (c) Study II Jalava et al., 1998 
 Emo (c) Study II Jalava et al., 1998 
 R53 (h) Study II Jalava et al., 2001 
    
    
H. pylori 26695 Study II Tomb, et al., 1997  
 P466 Study II Monteiro et al., 2000 
    
Campylobacter species 
C. jejuni 81-176 Study II Black et al., 2007 
 11168 Study II Gaynor et al., 2004 
    
Escherichia coli strains 
 TOP10 Study IV Invitrogen 
 JM109 Study II Promega 
 AD202 Study II Akiyama et al., 1990 
 DH5α Study II Hanahan 1983 
H. bizzozeronii CIII-1 
ORG
: original corpus-derived H. bizzozeronii was isolated in March 2008; CIII-1 
GEN
: 
isogenic reference genome was obtained from a single colony of a corpus-derived population CIII-1
ORG
; AII-2, 
AI-3, AII-4 - H. bizzozeronii antrum isolates were taken in March 2008 ; IA-1, IA-2, IA-3: H. bizzozeronii 
antrum isolates were taken in November 2008; §: Spontaneous metronidazole resistant H. bizzozeronii isogenic 
mutants; h-human isolates; c- canine isolates. 
All PCR reactions were performed by using the Phusion® High-Fidelity DNA Polymerase 
(Thermo Scientific) and 25 pmol of specific primers. In study III, cDNA was synthesized 
from 1 µg of total RNA using SuperScript III reverse transcriptase (Invitrogen), and random 
hexamers (Finnzymes). Reverse transcription (RT)-PCRs (40 cycles) were conducted with a 
total volume of 50 µl, using the Phusion high-fidelity DNA polymerase (Finnzymes), 1 µl of 
cDNA and 1 µl of RNA without reverse transcriptase as a negative control, and 20 pmol 
primers specific for the GT-42 locus. The primers used in this thesis are listed in table 2. 
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Table 2. Oligonucleotides used in this study 
Oligonucleotide name Sequences  
Amplification and sequencing of HBZC1_00960 (rdxA) (Study IV) 
HBrdxAupFW-PstI ATTCTGCAGTGCAACACCCCAAACCCCTACACCATG 
HBrdxAupRw-XbaI CATCTAGACCACGCAGATAATCCGCATTGAGAGAACC 
HBrdxAdwFW-KpnI ATAGGTACCGGTTCTCTCAATGCGGATTATCTGCGTGG 
HBrdxAdwRW-EcoRI ATGAATTCTACTTGCTCAAAGCCACTTGATCGC 
RdxAoutFw TTCAAACGCGCCCAAGAGAGC 
RdxAoutRw GCGACCAACGCCAAGCCCAAGAC 
  
Expression recombinant proteins (Study II) 
HBS-01  
MJS14 GGAGGAGAATTCCATATGAAACCCTTAATCATCGCCGGT 
MJS15 GGAGGAGTCGACTTATTACCCCCCAATATCAGGCGCATCTGG 
HBS-02  
MJS18 GGAGGAGAATTCCATATGCCACTTAAGCCCCTCATCGTTGCCGGC 
MJS19 GAGGAGTCGACTTATTACCCTCCCGTAGCCCTATGGCGTTTAAAC 
  
Amplification and sequencing GT42 locus and RT-PCR (Study II) 
NeuAE1 AAATGGGTGTTAGGCGGTGGTTG 
NeuAE2 TAAGCTGGTGTTGGGCGTTAGGG 
NeuAE3 AAGTGGCTCTCAGGGCGTGAAAC 
NeuAE4 CACCATTAGCGGGCTTTTAGAAGC 
NeuAE5 CAGCGTGCATTTGGTTACAGAGC 
NeuAE6 ACCAAGTAGAAACCCTAACGCCCAACACC 
NeuAE7 ACATCCACCAAGTAGAAACCCTAACGC 
NeuBE1 GCCCGGAGCGATGTTAGCAATAG 
NeuBE2 GCCCTTAGTGGTGGCTGAAGTGG 
NeuBE1rc TTGCTATTGCTAACATCGCTCCG 
NeuBE3 AGACTTTGGGACGGGTGGCTAAGGTG 
NeuCE1 CGGCTACCCAAATTCAAGCAAGG 
NeuCE2 TTTGCCCCGTGCCAAAATGATAG 
NeuCE3 TTGTGTGTGGCATGCACCTTTTG 
NeuCE4 CACCACTTTCTTGCCCTGCAACG 
NeuCE5 TATGACGGATGCTCTCATCTAAAGTCC 
NeuCE6 GAGCTTAGCGGGACTTTAGATGAGAG 
hbs1-a TAGCCACCTAGTTGCGTGCGATG 
hbs1-b TCCAATATGGTCGTTTCTTTCTTGTTGG 
hbs1-c CTCTCTGCAATCTTACCCTTGAGCC 
hbs1-c(rc) GGCTCAAGGGTAAGATTGCAGAGAG 
hbs1-d AATCCGGTGGGAATAAACTATAATCGAGG 
hbs1-e TATAGCCTGCATGTCTAGCTCTTGG 
hbs2-a AGCGCATAAAGCTGGGCGTATTG 
hbs2-b AAGGCTGTAATCTAAATCTTTAATGCTCGG 
hbs1-fw CGCAAAGATGGCGGATCGCTTAAC 
hbs1-rw TTGTGTGCAGGTCTAAAAAGGGTTTTAGAGTGG 
promSAB1F TCTTTACTTGTCCATTGGTTTTGGT 
promSAB1R TCTAAACTCCCATTATGGTTGATCC 
promSAB2F GATCGAAAATAGAGGCGTTCTTGTA 
promSAB2R CTTGGCAATCTCTAAACTCCCATTA 
RTHBS2rw1 CCATGTTCAAACCTTTGTAAATGAGATTGTC 
  
SSCP/ heteroduplex analysis (Study II) 
SSCPNeuCE5b ATTTAGACACGCTGTGGCGGATACTCTCATCTAAAGTTC 
SSCPNeuCE3b TTATGCGATCTTTGTGTGTGGCATGCACCTTTTGG 
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6.3 Single Strand Conformation Polymorphism (SSCP)/heteroduplex analysis (III)  
To verify the presence of heterogeneous homopolymeric tracts in putative UDP-N-
acetylglucosamine 2-epimerase (neuC) in different human and canine H. bizzozeronii strains, 
SSCP/heteroduplex analysis was performed by using the Phusion® High-Fidelity DNA 
Polymerase and primers SSCPneuCE3b and SSCPneuCE6b. The PCR products were mixed 
with the same volume of formamide loading buffer (80% formamide in 10mM EDTA, 
1mg/ml of Xylene and 1mg/ml of bromophenol blue), then incubated at 90°C for 3 min, 
cooled down in ice, loaded in 10% Criterion TBE Gels (Bio-Rad Laboratories, Hercules, CA) 
and run at 150V at 4°C for 4 h. The gels were then stained with ethidium bromide and images 
were acquired by Alphaimager (Alpha Innotech, San Leandro, CA). 
 
6.4 Genome sequencing and assembly (I, II & III) 
The genome sequence of H. bizzozeronii CIII-1
GEN
 was obtained by using 454 Titanium (43x 
genome coverage, 8 kb mate pair library, performed by LGC Genomics GmbH, Berlin, 
Germany) combined with Solexa (50 cycles, 132x coverage, 5 kb mate pair library, 
performed by Base Clear BV, Leiden, Netherlands). The genome was assembled into 2 
scaffolds that represented a circular chromosome and a circular plasmid by using the MIRA 
3.2.1, SSAKE and the Staden software package (Staden, et al., 2000, Warren, et al., 2007). 
The assembly of the chromosome was validated by mapping it to a MluI optical map 
produced by OpGen Inc. (Gaithersburg, Maryland, USA).  
 
In study II, A draft genome of H. bizzozeronii strain Storkis
T
 (CCUG 35545
T
) was 
sequenced by using the 454-pyrosequencing technique (Roche Diagonostics GmbH, 
Mannheim, Germany) with about 30-fold coverage and assembled in 147 contigs greater than 
500 bp. The contigs were automatically annotated using the RAST server (Aziz, et al., 2008). 
 
In study III, the sequence libraries of antrum-derived H. bizzozeronii were generated by 
using equal amounts of DNA that had been extracted from bacterial masses which had been 
isolated from each biopsy (March 2008 = T0; November 2008 = T1) and pooled for each time 
point. Sequence libraries were sequenced using Illumina technology and the Illumina reads 
were trimmed using Condetri perl script (Smeds & Kunstner, 2011) with default settings. 
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6.5 Annotation and comparative genomics (I & III) 
Gene annotation and comparative genomics between H. pylori and H. bizzozeronii were 
performed in study I. The sequences were uploaded to the RAST server (Aziz, et al., 2008) 
for gene finding and automatic annotation. We further analysed the coding sequences using 
the Artemis tool (Rutherford, et al., 2000) and manually re-annotated those genes of special 
interest. The homologues were identified using NCBI’s BLAST suite of programs with NCBI 
nr and nt and Swissprot as the reference databases. Two proteins with amino acid identity 
greater than 40% for more than 80% of their respective sequence length were considered 
homologues. The conserved functional domains in proteins were identified using the hmmer 
program on Pfam database (Finn, et al., 2010) and also the InterProScan (Mulder & Apweiler, 
2007). We predicted glycosyltransferases, glycoside hydrolases, polysaccharide lyases and 
carbohydrate esterases, by referring to the available annotation in the CAZy database 
(Cantarel, et al., 2009). The metabolic pathways were reconstructed using KEGG and SEED 
as reference databases (Aoki & Kanehisa, 2005, Aziz, et al., 2008). The subcellular locations 
of proteins were predicted by using the PSORTb tool via the psort web server (Yu, et al., 
2011), and signal peptides were identified using SignalP (Yu, et al., 2004), TatP (Bendtsen, et 
al., 2005) and LipoP (Juncker, et al., 2003). 
 
We identified the proteins unique to H. bizzozeronii and also those proteins found in H. pylori 
but which were missing from H. bizzozeronii, by determining the core genome of 10 H. 
pylori strains (J99, 26695, B8, HPAG1, B38, P12, G27, Shi470, SJM180 and PeCan4) using 
OrthoMCL with a BLAST Evalue cut-off of 1.0 e-6 and an inflation parameter 1.5 (Li, et al., 
2003).  
 
We identified the putative outer membrane proteins of H. bizzozeronii by using the BLASTp 
against the OMP database (Tsirigos, et al., 2011) and a set of known and categorised OMPs 
that had been obtained from H. pylori  (Alm, et al., 2000) by using the BLASTp score ratio 
cut-off of 0.4 (Rasko, et al., 2005).  
 
The H. bizzozeronii CIII-1 chromosome was searched for by utilizing simple sequence 
repeats (SSRs) potentially involved in slipped-strand misparing by using Msatfinder. The 
positions of each of the SSRs (intergenic or intragenic) were identified using Artemis 
(Rutherford, et al., 2000). The lengths of all of the intragenic SSRs were artificially modified 
to assess the likely significance of variations in the repeat-length on the expression of the 
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associated reading frame. 
 
The regions in the genome that were possibly acquired by horizontal gene transfer events and 
genomic islands were predicted by using Alien Hunter (Vernikos, et al., 2006) and Island 
Viewer (Langille & Brinkman, 2009) respectively. The potential prophage loci within the 
genome were predicted using the Prophage finder (Bose & Barber, 2006). The possible IS 
elements were identified by the semiautomatic annotation system provided by ISsaga and 
were subsequently manually checked (Varani, et al., 2011). 
 
In study III, comparative genomics analyses between antrum-derived H. bizzozeronii 
populations were performed, whereby the Illumina reads from pairs for which both reads had 
passed the quality threshold were aligned to the isogenic reference genome CIII-1
GEN
 using 
SSAHA2 (Ning, et al., 2001) as part of the Breseq pipeline v0.17 (Barrick, et al., 2009, 
Jerome, et al., 2011). We were interested in identifying any polymorphic sites (PS) for which 
the mutations could occur in only a fraction of H. bizzozeronii population, to do so we used 
the Breseq computational pipeline model (Barrick et al. 2009), which allowed the population 
to have an arbitrary mixture of the two most frequent bases at each position in the genome 
(Jerome et al., 2011). This approach allowed the identification of the mutations and also their 
frequencies, which were reported as the reads that contained a mutation as a percentage of the 
total number of reads mapped to a specified position. This approach yielded an estimation of 
the heterogeneity displayed in the antrum-derived H. bizzozeronii population at both time 
points (T0 and T1). 
 
6.6 Phylogenetic analysis (II) 
We investigated the evolution of Helicobacter STs and predicted functional activities of Hb-
ST1 and Hb-ST2, by using a phylogenetic analysis of GT-42 STs amino acid sequences that 
were performed by MEGA5 (Tamura, et al., 2011) and which used the Minimum Evolution 
(ME) method. The amino acid sequences were aligned using MAFFT (Katoh, et al., 2009). 
The evolutionary distances were computed using the Dayhoff matrix-based method, and the 
ME tree was searched using the Close-Neighbor-Interchange (CNI) algorithm (level 1). All 
positions with less than 90% site coverage were eliminated. A tree was drawn using 
TreeGraph 2. 
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6.7 Purification and characterization of recombinant H. bizzozeronii sialyltransferases 
(III) 
Hb-ST1 and Hb-ST2 genes were amplified by PCR as described above (Section 6.2). The 
amplified product was inserted into the NdeI and SalI restriction sites of pCW-malET as 
previously described (Bernatchez et al., 2007). Both expression constructs were transformed 
into E. coli AD202 as described previously (Akiyama & Ito, 1990). The expression of 
recombinant proteins was induced by using 0.5 mM isopropyl- β-D-thiogalactopyranoside 
(IPTG) at 25°C in 2YT medium supplemented with 150 mg/L of ampicillin and 0.2% of 
glucose for 24 h. After the 24 h period of induction had elapsed bacterial masses were 
collected and recombinant proteins were purified by affinity chromatography on amylose as 
previously described (Bernatchez, et al., 2007). The eluted fractions were analyzed on a 10% 
acrylamide gel, and the pure fractions were pooled and tested for the ST activity.  
 
The ST activities were subsequently examined by using a 0.5 mM solution of one of the 
following 6-(5-fluorescein-carboxamido)-hexanoic acid succimidyl ester (FCHASE)-labeled 
acceptors: FCHASE-GM3, FCHASE-lactose, FCHASE-LacNAc, FCHASE-lacto-N-biose, or 
FCHASE-T antigen by capillary electrophoresis as previously described (Wakarchuk & 
Cunningham, 2003). Kinetic analysis of the purified protein was performed by using various 
concentrations of FCHASE-LacNAc that ranged from 0.0201 to 1.415mM, in the presence of 
2 mM CMP-Neu5Ac under the optimized reaction conditions. Once the Km for FCHASE-
LacNAc was determined, we repeated the kinetic assay using concentrations of CMP-
Neu5Ac that ranged from 0.01476 to 1.5236mM with 1 mM FCHASE-LacNAc. 
 
6.8 LPS extraction, LPS profile in SDS-PAGE and affinity blotting (II) 
Crude LPS from H. bizzozeronii strains, were extracted using the hot phenol-water method 
and were subsequently purified by enzymatic treatments (RNase A, DNase II and proteinase 
K; Sigma-Aldrich) as described previously (Hynes, et al., 2004). The LPS obtained from H. 
bizzozeronii CIII-1 and Storkis
T
 were extracted by the phenol-chlorofom-light-petroleum 
method as previously described for structure analysis (Galanos, et al., 1969) but with the 
modification of LPS precipitation by acetone/diethylether (6:1, v/v). The crude LPS extracts 
were purified by ultracentrifugation (75,000×g at 4°C for 16h). O-deacylated LPS (LPS-OH) 
were obtained as previously described (Holst, et al., 1991). The concentrations of purified 
LPS were measured using a purpald assay as described previously (Reeves, et al., 2008).   
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We determined the presence of sialic acid. Two micrograms of LPS from each sample was 
treated at pH 6 with 6.7 IU of neuraminidase of C. perfringens (Sigma-Aldrich) overnight at 
37°C and boiled for 5 min. The patterns of LPS isolated from different strains before and 
after neuraminidase treatment were determined after fractionation by 15% Tris-HCl SDS-
PAGE (Bio-Rad) and stained with silver as previously described (Hynes, et al., 2004). 
 
 H. bizzozeronii strains were cultivated in BHI broth as described above (section 6.1) for 48 h, 
to obtain affinity blotting. After the incubation, bacterial cell masses were harvested in PBS 
at pH 7.2 (OD600=1) and treated with Proteinase K (0.4mg/ml) at 56°C for 1 h, then boiled for 
5 min. The neuraminidase treatment was as described above. Two µl of the extract was 
spotted onto a nylon membrane and blotting was performed using 0.1% peroxidise-
conjugated cholera toxin subunit B (po-CT; Sigma Aldrich) and Anti-sialyl-LewisX (1:1000, 
BD Pharmingen). Horseadish peroxide-labeled secondary goat Anti Mouse IgM (1:1000, BD 
Pharmingen) was used as a secondary antibody for Anti-sialyl-LewisX blotting. E. coli DH5α 
was used as a negative control, whereas C. jejuni 11168 and H. pylori P466 were used as 
positive controls for po-CT and Sialyl-Lewis X, respectively.  
 
6.9 Chemical and structural analysis of H. bizzozeronii LPS (II) 
We determined the presence of Neu5Ac in hot phenol-water extracted LPS from different 
canine human isolated H. bizzozeronii strains. High performance anion exchange 
chromatography with pulsed amperometric detection (HPAEC-PAD) was used as previously 
described (Bauer, et al., 2001). The HPAEC-PAD was performed using a Dionex series 
4500i chromatography system (Dionex, Sunnyvale, CA) using a CarboPac PA20 column.  
The structure of LPS-OH from H. bizzozeronii strains CIII-1 and Storkis
T 
were analysed by 
Capillary Electrophoresis Electrospray Ionisation Mass Spectrometry (CE-ESI-MS). CE-ESI-
MS was performed by using a Prince CE system (Prince technologies, Netherlands) coupled 
to a 4000 QTRAP mass spectrometer (AB Sciex, Canada) with microIon spary interface, as 
described previously (Li, et al., 2004).  
 
6.10 Antimicrobial susceptibility of H. bizzozeronii strains (III & IV) 
Minimum inhibitory concentration (MIC) values for metronidazole (Mtz; Sigma-Aldrich) and 
tetracycline (Tet; Sigma-Aldrich) for canine and human derived H. bizzozeronii strains were 
obtained by using an agar dilution method. Briefly, HP agar plates supplemented with serial 
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dilutions of the antibiotics were inoculated with 10 µl containing 10
3
 cfu of bacterial cells. 
The MIC values were determined after 4 and 6 days of incubation at 37°C in the 
microaerobic incubator. The EUCAST 2012 clinical breakpoints for metronidazole (> 8 
µg/mL) and tetracycline (> 1 µg/mL) described for H. pylori were also used to classify H. 
bizzozeronii as either resistant or sensitive (EUCAST clinical breakpoints). 
6.11 Selection of spontaneous metronidazole resistant H. bizzozeronii isogenic mutants 
(IV) 
Spontaneous metronidazole resistant H. bizzozeronii mutants were selected by a single 
passage in media containing four times the MIC of metronidazole. Briefly, a suspension 
containing approximately 10
6
 cfu/mL of 3-day-incubated H. bizzozeronii CIII-1
GEN
 (MIC 4 
µg/ml) was prepared in BHI-Fbv and allowed to grow in a biphasic medium (HP coupled 
with BHI-Fbv) for 36 h. Then, 100 µl of the suspension was spread onto HP agar plates 
containing 16 mg/L of metronidazole. After six to ten days of incubation, resistant colonies 
were identified and transferred once to a fresh HP plate containing 16 mg/L of metronidazole 
before being frozen at —70°C in 10% glycerol until analysis. Subsequently, these 
spontaneous metronidazole resistant H. bizzozeronii mutants were named as CIII-1
GEN 
M. 
The H. bizzozeronii rdxA homolog (HBZC1_00960) obtained from each mutant was 
amplified and sequenced.  
 
6.12 Construction of H. bizzozeronii ∆rdxA isogenic mutants (IV) 
H. bizzozeronii CIII-1
GEN 
and H. bizzozeronii CCUG 35545
T 
strains were used to construct 
the H. bizzozeronii rdxA::cat isogenic mutants. Briefly, chromosomal inactivation of the 
HBZC1_00960 (rdxA) gene was achieved by allelic exchange using the chloramphenicol 
resistance gene (cat) as previously described (Rossi, et al., 2012). The cat gene was 
introduced in the same direction of the target gene using XbaI and KpnI restriction sites. The 
resultant plasmid, pCP5, was constructed and amplified in E. coli TOPO10 (Invitrogen, 
Carlsbad, CA) and used as a suicide plasmid for H. bizzozeronii. Mutants were obtained by 
electroporation as described for H. felis (Josenhans, et al., 1999). After electroporation, the 
bacteria were cultivated to recover on HP agar plates under microaerobic conditions for 48 h. 
The mutant strains H. bizzozeronii rdxA::cat were selected on HP agar plates that were then 
supplemented with chloramphenicol (10 mg/L). The plates were incubated for up to 10 days  
and the site of recombination was verified from DNA that had been isolated from the 
bacterial growth by PCR. 
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6.13 Determination of mutation rate and mutation frequency (IV) 
Luria-Delbrück fluctuation analysis (Rosche & Foster, 2000) was used to determine the 
mutation rate and frequency of H. bizzozeronii for metronidazole. Briefly, a suspension of H. 
bizzozeronii CIII-1
GEN
 containing approximately 10
6 
cfu/mL was prepared in BHI-Fbv broth 
and divided into 24 aliquots of 0.5 mL. These aliquots were allowed to grow in biphasic 
medium (HP coupled with BHI-Fbv) for 36 h to obtain parallel, independent cultures. The 
number of resistant mutants that emerged from each culture was determined by plating an 
aliquot of the culture onto HP agar plates containing 16 mg/mL of metronidazole. The total 
number of cells (Nt) was determined by plating an appropriate dilution of three cultures on 
non-selective medium. Colonies that grew on both selective and non-selective plates were 
counted after a maximum of 10 days of incubation. The frequency of resistant mutants was 
expressed as the mean number of resistant cells divided by the total number of viable cells 
per culture. The mutation rate was calculated by taking the most likely number of mutations 
per culture observed (mobs) was calculated from the distribution of numbers of resistant 
mutants in the independent cultures by Ma-Sandri-Sarkar maximum-likelihood method 
(Rosche & Foster, 2000) using FALCOR web tool (Hall, et al., 2009).  
 
6.14 Time-kill curve for metronidazole (IV) 
The possible reversibility of metronidazole resistance in H. bizzozeronii was determined after 
serial in vitro passages by generating time-kill curves. Briefly, H. bizzozeronii strain CIII-
1
GEN
 and its derivate CIII-1
GEN 
rdxA::cat and CIII-1
GEN 
M11 were sequentially sub-cultivated. 
CIII-1
GEN
 was maintained on non-selective plates, CIII-1
GEN
 rdxA::cat in the presence of 16 
µg/mL of metronidazole and CIII-1
GEN 
M11 was maintained on plates under both conditions. 
After 10, 12 and 15 passages, approximately 10
8 
cells/mL of each sub cultivated H. 
bizzozeronii strain were suspended in BHI-Fbv with or without 32 µg/mL of metronidazole. 
After 16 h had elapsed the intracellular ATP (Adenosine Tri-phosphate) levels were 
measured using BacTiter-GloTM (Promega). The determinations were performed in duplicate. 
The data were analysed as percentages of Relative Light Units (RLU) of the treated samples, 
which were compared to their untreated ones. Statistical analysis was performed by applying 
One-way ANOVA analysis of variance followed by Tukey's Multiple Comparison using 
GraphPad Prism version 4.03 for Windows (GraphPad Software, San Diego California USA, 
www.graphpad.com). 
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7. RESULTS  
7.1 Comparative genomic analysis (I & II) 
7.1.1 General features of H. bizzozeronii genome (I) 
Human derived H. bizzozeronii CIII-1 genome was analysed in study I. H. bizzozeronii CIII-
1 was shown to possess all the genes necessary for its specialized life in the host’s stomach. 
We identified 1894 protein-coding DNA sequences (CDS) in a coding area of 93% of the H. 
bizzozeronii CIII-1 genome and a putative function could be predicted for 1280 (67.7%) of 
the CDS, whereas 614 (32.4%) of the CDS were annotated as hypothetical proteins. A 
summary of the features of the H. bizzozeronii CIII-1 genome is provided in study I (Table 1, 
Pages 3 & 4), and a circular plot of the chromosome showing GC content and GC skew is 
presented in Figure 1. 
 
7.1.2 Comparative genomics H. bizzozeronii CIII-1 versus H. pylori (I) 
We performed a detailed comparative genome analysis between H. pylori and the human 
strain of H. bizzozeronii CIII-1. We identified 1034 proteins in common in the core genome 
of H. pylori and H. bizzozeronii CIII-1. In addition, we identified 88 CDS with predicted 
functions, which are unique to H. bizzozeronii CIII-1. Excluding the proteins associated 
either with bacteriophage or with plasmid replication, the functions of the majority of the 
unique H. bizzozeronii genes are linked to chemotaxis and to metabolism (Figure 1). The 
summary of the results is presented below. A complete description of the results is available 
in study I. 
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Figure 1. Circular representation of the Helicobacter bizzozeronii CIII-1 chromosome. From the outside in: the 
outer circle 1 shows the size in base pairs; circles 2 and 3 show the positions of CDS transcribed in a clockwise 
and anti-clockwise direction, respectively (for colour codes see below); circle 4 shows the position of insertion 
elements (IS and mini-IS, violet); circle 5 shows the results obtained by the Alien Hunter program from the 
lowest score (light pink) to the highest score (red) (threshold score value: 16971); circle 6 shows the positions of 
the genomic island (brown) and prophage (orange); circle 7 shows a plot of G+C content (in a 10-kb window); 
circle 8 shows a plot of the GC skew ([G_C]/[G+C]; in a 10-kb window). Genes in circles 2 and 3 are color-
coded according to the following categories: wine red, genes involved in central metabolism and respiration 
without orthologues in H. pylori; cyan, methyl-accepting chemotaxis proteins (MCPs); dark blue, type IV 
secretion system; sky blue, genes involved in acid acclimatization; green, putative secreted virulence factors; 
pale green, glycosyltransferse gene cluster specific of H. bizzozeronii; pale grey, all other CDSs. ACC, 
acetophenone carboxylase; comB, Type IV secretion system; NAP, periplasmic nitrate reductase; AHD, 
allophanate hydrolase; GT, glycosyltransferase; NRS, nitrite reductase system; SNO, S- and N- oxidases; FDH, 
formate reductase system; PL, polysaccharide lyase.  
 
H. bizzozeronii CIII-1 was shown to possess all genes necessary for a specialized life in the 
stomach, but it differs from H. pylori by having a wider metabolic flexibility in terms of 
energy sources (Figure 2) and the electron transport chain (Figure 3). In addition to the 
nickel-dependent urease, H. bizzozeronii was found to possess two copies of putative 
allophanate hydrolase that may contribute to the acid acclimatization of the species. 
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Moreover, the H. bizzozeronii genome harbours higher numbers of gene encoding methyl-
accepting chemotaxis proteins compared to H. pylori (Figure 1). We also identified a putative 
polysaccharide lyase (PL) as a potential new virulence factor of H. bizzozeronii. A 
homologue of this protein was not present in any of the H. pylori strains that we compared 
(shown as PL in Figure 1,). We identified a high level of genome plasticity in H. bizzozeronii 
CIII-1 and it was shown to have 43 contingency genes, 5 insertion sequence (IS), 22 mini-IS 
elements, 1 genomic island and a putative prophage. 
  
 
Figure 2. Schematic representation of the central metabolism (predicted citric acid cycle and anaplerotic 
reactions) of H. bizzozeronii CIII-1. In red are the reactions that are predicted to be present in H. bizzozeronii 
CIII-1 but not in H. pylori. In black are the reactions predicted to be common to both Helicobacter species. 
Reactions for which no predictable enzymes were found in the genome are indicated by dotted line. The H. 
bizzozeronii gene numbers are indicated in boxes. The central metabolism of H. bizzozeronii, which is inferred 
from the genome of the human strain CIII-1, seems to be more flexible than that of H. pylori 
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Figure 3. Schematic representation of the respiratory pathway of H. bizzozeronii CIII-1. In red are the reactions 
that are predicted to take place in H. bizzozeronii CIII-1 but not in H. pylori. In black are the reactions predicted 
to be in common for both Helicobacter species. In blue TMAO/DMSO reduction, which could also be predicted 
in H. pylori but a complete set of enzyme is not present. The arrows indicate the direction of the electrons to or 
from the membrane-bound electron transport chain. Dashed lines indicate that the direction of the electrons is 
unknown. Enzymes that catalyze key reactions are indicated in boxes. FDH, formate dehydrogenase; HYD, 
hydrogenase; NRS, nitrite reductase system; SNO, S- and N- oxidases; GDH, glycerol-3-phosphate 
dehydrogenase; NDH, NAD(P)H dehydrogenase; SDH/FR, succinate dehydrogenase/fumarate reductase; MQR, 
malate-quinone-reductase; LDH, lactate dehydrogenase; GLC, glycol oxidase; NAP, periplasmic nitrate 
reductase; Q, quinone; Cyt b/c1, quinone cytochrome oxidoreductase; Cyt c, cytochrome c; cbb3, cytochrome c 
oxidase; ccP, cytochrome c peroxidase. The respiratory chain in H. bizzozeronii appears to be highly branched 
and more complex than described for H. pylori 
 
7.2 Biosynthesis of sialylated LPS in H. bizzozeronii (II) 
7.2.1 Identification of GT-42 family sialyltransferases (STs) in H. bizzozeronii (II) 
The genome sequence analysis of human derived H. bizzozeronii strain CIII-1, showed the 
presence of three genes (neuABC), which are known to be involved in the biosynthesis of 
sialic acid (Neu5Ac). Downstream of the neuABC, we observed the presence of a 
glycosyltransferase (HBZC1_02560) that belongs to the glycosyltransferase family GT-42. A 
similar cluster was also found in the shotgun genome sequence of H. bizzozeronii strain 
Storkis
T
, that had been isolated from a dog. However, a tandem of GT-42 ST (denominated 
Hb-ST1 and Hb-ST2) was found downstream of the putative neuA gene in the canine strain. 
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These two Storkis
T
 GT-42 STs shared only 48.8% of the amino acid sequence identity. In 
comparison HBZC1_02560 showed 49.6% and 97.8% identities to Storkis
T
 Hb-ST1 and Hb-
ST2, respectively. Further, we predicted functional activities of Hb-ST1 and Hb-ST2 
(HBZC1_02560) and evolution of Helicobacter STs (Study II, Figure 1) by a phylogenetic 
analysis using minimum evolution (ME) based on amino acid sequence alignments. 
  
The conserved synteny of the GT-42 locus was determined for different Helicobacter spp. 
With the exception of H. mustelae, all other species showed co-linearity in the gene order: the 
neuBCA cluster was followed by one copy (H. bizzozeronii CIII-1) or two copies (all other 
Helicobacter spp.) of ST encoding genes in the same transcriptional direction (Figure 4). 
Further amplification and partial sequence analysis of the GT-42 locus from human and 
canine H. bizzozeronii strains, revealed variations both in the number of STs in addition to 
positions of single sequence repeats (SSR) across the strains, which indicate different 
modulation in the expression of glycans containing sialic acid in H. bizzozeronii (Figure 5). 
The SSCP analysis of the 240-bp PCR product (neuC) that contained the SSRs of all studied 
strains showed multiple bands that revealed the presence of heterogeneous homopolymeric 
tracts and confirmed the contingency nature of neuC. 
 
Furthermore, the two novel STs from H. bizzozeronii (Hb-ST1 and Hb-ST2) were tested for 
their activities on several substrates (study II). We did not observe Hb-ST1 activity on any 
acceptor we tested in the enzyme assay, but Hb-ST2 showed mono functional α,2,3-ST 
activity with a strong preference for LacNAc over Lac and very low levels of activity on 3-
linked Gal. 
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Figure 4. Schematic representation and comparison of the GT-42 loci of different Helicobacter species. Empty 
arrows represent the direction of transcription of the open reading frames within each locus. Black boxes 
correspond to the positions of simple sequence repeat (SSR) of cytosine or guanine. Grey boxes indicate repeat 
regions of 8 to 15 units composed of six (KELERQ) or 10 (FKNIEEKLLE) amino acids. In parentheses are the 
length of the GT-42 locus for each species. b, N-acetylneuraminic acid synthetase (neuB); c, UDP-N- 
acetylglucosamine-2-epimerase (neuC); a, CMP-sialic acid synthetase (neuA); s, sialyltransferase (with the 
corresponding phylogenetic group indicated). 
                        
Figure 5. Schematic representation and comparison of the GT-42 loci of different H. bizzozeronii strains. Empty 
arrows represent the direction of transcription of the open reading frames within each locus. Black boxes 
correspond to the positions of simple sequence repeats (SSR) of cytosine or guanine. Black arrows indicate the 
insertion in the promoter region of the mini-IS. b, N-acetylneuraminic acid synthetase (neuB); c,UDP-N-
acetylglucosamine-2-epimerase (neuC); a, CMP-sialic acid synthetase (neuA); s, sialyltransferase (with the 
corresponding phylogenetic group indicated). 
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7.2.2 Sialic acid-containing structure in H. bizzozeronii LPS (II) 
Affinity blotting revealed that po-CT was able to bind to Yrjälä and CIII-1 (Figure 6A). No 
binding to StorkisT, Heydar, and R53 were observed but after neuraminidase treatment, po-
CT reacted with all the strains tested. Different results were observed when the strains were 
tested with anti-sialyl-Lewis X antibodies, which reacted strongly with R53 but weakly with 
Yrjälä, and no binding to other strains was observed (Figure 6B). After neuraminidase 
treatment, anti-sialyl-Lewis X antibodies were not able to react with R53 and Yrjälä. 
 
 
Figure 6. Affinity blotting of a proteinase K extract from H. bizzozeronii strains untreated (line 1) or treated 
with neuraminidase from Clostridium perfringens (line 2). Affinity blotting was accomplished by using 
peroxidase-conjugated cholera toxin subunit B (A) and anti-sialyl-Lewis X antibodies (B).  
 
H. bizzozeronii strains expressed a low-molecular-weight LPS, and a clear shift of the band 
appeared after neuraminidase treatment (Figure 7), which indicated that H. bizzozeronii could 
expresses sialylated LPS. In addition, we determined the presence of Neu5Ac in the LPS of 
four strains (Heydar, R53, Storkis
T 
and CIII-1) by high performance anion-exchange 
chromatography with pulsed amperometric detection (HPAEC-PAD).  
 
 
 
 
 
 
 
 
 
Figure 7. SDS-PAGE analysis of LPS from different H. bizzozeronii strains treated with neuraminidase 
obtained from Clostridium perfringens (marked by asterisks) or untreated with neuraminidase. Black arrow 
mark corresponds to the positions in sifting the bands after the neuraminidase treatment; M: marker. 
 
Structural analysis of LPS-OHs obtained from H. bizzozeronii strains CIII-1 and Storkis
T
, 
showed that they contain a core oligosaccharide linked via one 3-deoxy-D-manno-oct-2-
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ulosonic acid (Kdo) molecule to a lipid A molecule. Mass spectrometry showed that the core 
oligosaccharide of H. bizzozeronii is composed of heptoses (Hep), hexoses (Hex), 
hexosamines (HexNAc), and deoxysugars (dHex) (Figures 8 and 9). Information on the 
nature of the sialylated oligosaccharide extensions in the LPS-OHs of both H. bizzozeronii 
strains was obtained by MS/MS experiments on protonated ions in the positive mode. When 
the ion at m/z 1,571.5 (Neu5Ac2·dHex3·HexNAc3 Hex7·Hep3·PEtn·Kdo·lipid A-OH [strain 
CIII-1, positive mode]) (Fig. 9B) was fragmented, ions at m/z 366 (Hex·HexNAc) and m/z 
657 were observed. The diagnostic fragment ion at m/z 657 corresponds to Neu5Ac-Hex-
HexNAc, which indicates that sialyllacto-N-neotetraose is present. 
 
 
Figure 8. The O-deacylated LPS of H. bizzozeronii strain CIII-1 analyzed by CE-ESI-MS in negative-ion mode 
(A) and CE-ESI-MS/MS with precursor ion scanning (B) on the ion at m/z 290, i.e., Neu5Ac. 
 
Figure 9. The O-deacylated LPS of H. bizzozeronii strain CIII-1 analyzed in positive-ion mode. Shown are data 
for analyses by CE-ESI-MS/MS of the ion at m/z 1323.2, corresponding to a composition of 
dHex3·HexNAc3·Hex6·Hep3·PEtn·Kdo·lipid A-OH, in the negative-ion mode (A), and CE-ESI-MS/MS on the 
ion at m/z 1571.5, corresponding to a composition of Neu5Ac2·dHex3·HexNAc3·Hex7·Hep3·PEtn·Kdo·lipid 
A-OH (B). 
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7.3 Antibiotic resistance and microevolution of H. bizzozeronii (III & IV) 
 
7.3.1 Antimicrobial susceptibility of H. bizzozeronii (III & IV) 
In study III, the antimicrobial susceptibility of the antrum-derived H. bizzozeronii population 
at T0 and T1 was evaluated by the agar dilution method for metronidazole and tetracycline 
and MIC values are listed in Table 3.  
 
The susceptibility of the corpus H. bizzozeronii population CIII-1
ORG
 and of its derived clone 
CIII-1
GEN 
were also studied. According to the EUCAST clinical breakpoints for H. pylori are > 
1 µg/mL for tetracycline and > 8 µg/mL for metronidazole (EUCAST, 2012). All strains were 
resistant to tetracycline. In contrast, the simultaneous presences of metronidazole susceptible 
and metronidazole resistant H. bizzozeronii variants were observed before the treatment. All 
the H. bizzozeronii variants, isolated after the treatment, were resistant to metronidazole (32 
µg/mL). In addition, in study IV, all the isogenic H. bizzozeronii mutants showed similar 
MIC values for metronidazole (32 µg/mL) as observed for the H. bizzozeronii variants 
isolated after the treatment (Table 3). 
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Table 3.  Metronidazole and tetracycline MIC values (µg/mL) of H. bizzozeronii strains before and after 
treatment. 
             MIC  (µg/mL) 
 
H. bizzozeronii strains 
 
Isolation period  
 
Mtz 
 
Tet 
 
Study 
H. bizzozeronii strains corpus and antrum isolates before (T0) and after  treatment (T1) 
CIII-1GEN T0  4 16 III & IV 
CIII-1ORG T0  32 16 III 
AII-2 T0  4 16 III 
AII-4 T0  4 8 III 
AI-3 T0  4 16 III 
IA-1 T1  32 16 III 
IA-2 T1  32 64 III 
IA-3 T1  32 16 III 
H. bizzozeronii CIII-1
GEN, Storkis CCUG 35545T and corresponding rdxA mutants 
CIII-1GEN C1 ∆ rdxA  32 ND IV 
CIII-1GEN C2 ∆ rdxA  32 ND IV 
Storkis CCUG 35545T  8 ND IV 
Storkis CCUG 35545T S1∆ rdxA  64 ND IV 
Storkis CCUG 35545T S2 ∆ rdxA  64 ND IV 
Spontaneous metronidazole resistant H. bizzozeronii Isogenic mutants 
CIII-1GEN M1 to CIII-1GEN M11  32 ND IV 
EUCAST clinical breakpoint for H. pylori EUCAST 2012 (Tet :>1 µg/mL; Mtz :> 8 µg/mL) 
7.3.2 Microevolution of H. bizzozeronii before and after antimicrobial therapy (III) 
In study III we identified a number of polymorphic sites (PS) among H. bizzozeronii 
population that was isolated from the patient before (T0) and also after (T1) the treatment. At 
T0, the total number of PSs that were detected in the H. bizzozeronii population was 128. 
Based on the percentage of reads that presented the mutation at each position the results were 
further divided into four groups (Table 4). For most of the PS (91.4%), the mutations 
appeared at frequencies of 50% or less, which indicated that the majority of the reads that 
belonged to the antrum-derived H. bizzozeronii population at T0 did not differ from the 
isogenic reference genome.  
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Table 4. Polymorphic sites detected in the antrum-derived H. bizzozeronii population at T0 and T1. The results 
were divided into four groups depending of the percentage of the reads that presented the mutation in each 
position 
 
                       Events 
Total < 25% 25%-50% 50%-75% > 75% 
T0 T1 T0 T1 T0 T1 T0 T1 T0 T1 
SNPs 
 
110 203 13 52 86 4 4 3 7 144 
Synonymous substitutions 
 
18 35 6 6 8 3 1 2 3 24 
Non-synonymous substitutions 
 
73 136 4 39 62 0 3 0 4 97 
Intergenic regions or non-coding 
DNAs 
 
19 32 3 7 16 1 0 1 0 23 
DIPs 
 
18 20 6 5 11 0 0 0 1 15 
Total 
 
128 223 20 57 97 4 4 3 8 159 
 
 
After the failed treatment (T1), the number of PS (223) detected in the H. bizzozeronii 
population increased extensively (Table 4). In contrast to that found for T0, the majority of PS 
(71.3%) at T1 contained mutations at a frequency of 75% or even more. Intriguingly, of the 
223 PSs detected at T1, 127 positions were not present at T0, 54 positions displayed the same 
mutation as detected at T0 but with a >1.5 fold increase in mutation frequency and 35 
positions displayed a >1.5 fold decrease in mutation frequency compared to observations at 
T0 (Figure 10). Interestingly, new mutations at T1 occurred more readily at a high frequency 
(>75%, Pearson’s chi-square test, P = 0.003571). Moreover, among the common PSs, the 
mutations occurring with frequencies of 75% or more showed a >1.5 fold increase compared 
to those observed at T0, while those occurring with frequencies of 25% or less at T1 had a 
higher frequency at T0.  
 
 
39 
 
              
Figure 10. Polymorphic sites (PSs) detected in the antrum-derived H. bizzozeronii population at T1 in 
comparison with those detected at T0 divided into four groups on the basis of the percentage of the reads that 
present the mutation in each position. (A) New: number of PSs absent in T0; Common: number of PSs present in 
both sampling points (B) Changes in frequency of the reads that present the mutation in T1 compared to T0: 
Increased: 1.5 fold increase; Decreased: 1.5 fold decrease; Equal: no differences 
 
We observed that non-synonymous substitutions or indels affected a total of 80 and 133 
CDSs in the antrum-derived H. bizzozeronii population at T0 and T1, respectively. We were 
able to classify approximately 66% of the mutated CDSs functionally and they are listed in 
Table 5.  
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Table 5. Functional classification of the mutated CDSs in the antrum-derived H. bizzozeronii population 
isolated at both time points  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additionally, we observed that, point mutations or indels affected the frame shift of several 
CDSs for both the populations in T0 and T1. We identified 10 intragenic homopolymeric 
tracts with repeat numbers of between 6 to 8 nucleotides that varied between the reads from 
the populations at T0 or at T1 (Table 6). The 10 genes that showed instability, encoded outer 
membrane proteins and proteins that are involved in the central metabolism, respiratory chain, 
cell motility and chemotaxis (Table 6).  
 
Function categories  
Mutated CDSs 
at T0 
Mutated CDSs 
at T1 
Unknown function 28 47 
Predicted function 53 87 
Motility and chemotaxis 15 19 
Respiratory chain 6 12 
Cell wall biosynthesis  5 11 
Proteolytic enzymes 2 5 
Gene regulation 2 4 
Protein synthesis 3 4 
Amino acid metabolism 2 3 
DNA replication 3 3 
Glycan biosynthesis 1 3 
Central metabolism 1 3 
Purine metabolism 2 3 
ABC transporters 1 2 
Bacterial replication 1 2 
Lipid metabolism 3 2 
Mobile elements 2 2 
Transporter 1 2 
Virulence-associated genes 1 2 
Acid acclimatization   0 1 
Cofactors  0 1 
DNA repair system 1 1 
Metals omeostasis 1 1 
RNA degradation 0 1 
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7.3.3 Contingency nature of rdxA in H. bizzozeronii (IV) 
In the multiple sequence alignment of the predicted amino acid sequences of the C-terminus 
of RdxA obtained from several Helicobacter species (Figure 11), the resistant H. bizzozeronii 
variant, Antrum T1, had frame length extensions of the RdxA homologue compared to the 
isogenic strain CIII-1
GEN
. This frame length extension was associated with the disruption of 
the C-terminal cysteine-containing conserved region IACLXALGK (amino acids from 
position 182 to position 190 of HBZC1_00960) and was the result of the insertion of a single 
cytosine located in the C-terminal of H. bizzozeronii rdxA (from codon 178 to codon 180 of 
HBZC1_00960) in a homopolymeric run. A 3 simple sequence cytosine repeat (SSCR) was 
also present in the same position in the rdxA of the type strain of H. heilmannii s.s., but was 
not present in the other gastric Helicobacter species studied (Figure 11). Furthermore, we 
sequenced the rdxA from several H. bizzozeronii spontaneous resistant mutants, and in all but 
one the extension of the SSCR (C8 to C9) located in position 178-180 was the only 
modification we observed. However, a single base deletion upstream of the SSCR in mutant 
M9 induced the formation of a premature stop-codon of RdxA, and an extension of the SSCR 
Table 6. List of the 10 genes, which showed unstable short-SSR in the antrum-derived H. bizzozeronii 
population. 
Position 
(bp) 
Locus_tag Description 
Variation 
detected 
In-frame 
ORF tract length* 
Frequency of 
In-frame ORF state 
T0 T1  
Central metabolism and respiratory chain 
98,504 HBZC1_00960 
Oxygen-insensitive 
NAD(P)H nitroreductase 
(rdxA) 
 
C8 to C9 C9 0 % 95.8% ↑ 
1,144,741 HBZC1_12300 
L-2-hydroxygluturate 
oxidase (lhgO) 
G8 to G9 G8 73 % 88 % ↑ 
Motility and chemotaxis 
325,928 HBZC1_03490 
Flagellar protein (flbB) 
 
C8 to C9 C8 0 % 100 % ↑ 
896,590 HBZC1_09500 
Putative methyl-accepting 
chemotaxis protein 
G7 to G6 G7 68 % 93 % ↑ 
Outer membrane proteins 
809,831 HBZC1_08590 
Putative outer membrane 
protein 
G8 to G7 
G7 (merged with 
HBZC1_08580) 
0 % 
78.9 
% 
↑ 
903,088 HBZC1_09570 
Putative outer membrane 
protein 
T8 to T7 T8 100 % 0 % ↓ 
939,820 HBZC1_10100 
Putative outer membrane 
protein 
T6 to T7 
T7 (merged with 
HBZC1_10110) 
33 % 100 % ↑ 
Other proteins 
128,638 HBZC1_01400 Hypothetical protein G7 to G8 G8 10 % 0 % ↓ 
549,532 HBZC1_05780 Hypothetical protein T8 to T7 
T7 (merged with 
HBZC1_05780) 
30.5 
% 
100 % ↑ 
1,661,749 HBZC1_17960 Replicative DNA helicase C7 to C6 C6 6.5 % 12 % ↑ 
* The ‘‘In-frame ORF tract length’’ was defined as the homopolymeric tract length that generated the longest potential open-
reading frame 
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was not observed (Study IV, Table 2). In addition, the mutation rate of H. bizzozeronii CIII-
1
GEN
 that became resistant to metronidazole was estimated as 1.74x10
-5
 by Luria-Delbrück 
fluctuation analysis (study IV Table 3).  
 
 
Figure 11. Multialignments of the predicted amino acid sequences of C-terminus of RdxA from different 
Helicobacter spp. The area where the simple sequence cysteine repeat is located in H. bizzozeronii is 
highlighted and the multialignments of the corresponding nucleotide sequences are shown. The C-terminal 
cysteine-containing conserved region is marked in bold. HBZ Antrum T1: H. bizzozeronii metronidazole 
resistant strain (MIC 32 µg/mL); HBZ CIII-1GEN: H. bizzozeronii isogenic metronidazole susceptible strain 
(MIC 4 µg/mL); HFE CS1: H. felis CS1
T
 (Hfelis_12350); HHE ASB1.4: H. heilmannii sensu stricto ASB1.4T 
(CCM10903); HCE MIT00-7128: H. cetorum MIT00-7128 (HCw_05595); HAY SHEEBA: H. acinonychis 
strain Scheeba (Hac_1030); HPY Puno135: H. pylori Puno135 (HPPN135_04725); HPY 26695: H. pylori 
26695 (HP0954); HPY B38: H. pylori B38 (HELPY_0940) 
 
Reversibility of the resistance to metronidazole of H. bizzozeronii was observed after several 
in vitro passages. The results are shown in Figure 12. Those data are plotted as a percentage 
of the relative light units (RLU) of the treated samples (with 32 µg/mL of metronidazole) 
compared to the untreated samples. After 16 h of exposure, the spontaneous metronidazole-
resistant isogenic mutant CIII-1
GEN 
M11 maintained on non-selective plates survived 
similarly to the wild type but significantly (p< 0.05) less well than CIII-1
GEN 
rdxA::cat. In 
contrast, when CIII-1
GEN
 M11 was maintained on selective plates, the percentage of survival 
was not significantly different to any of the other conditions tested. However, in the absence 
of metronidazole, CIII-1
GEN
 M11 survived less well than the same strain maintained in 
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medium containing the antibiotic. Therefore, although no statistical significance was found 
between the survival capability of CIII-1
GEN
 M11 when sub-cultivated with or without 
metronidazole, it tends to become more susceptible in the absence of selection after a small 
number of in vitro passages.  
 
  
                 
Figure 12.  Killing effect of metronidazole (Mtz) after 16 h of exposure against H. bizzozeronii strains. The 
figure shows the time-kill curve for H. bizzozeronii strains CIII-1
GEN
, its derivate CIII-1
GEN
 ΔrdxA and CIII-
1
GEN
 M11 maintained in the presence or absence of Mtz (marked with MTZ in the figure). Data are plotted as 
the percentage of intracellular ATP, shown as relative light units (RLU), of the treated samples compared to the 
untreated ones. Means statistically significant different from the wild type strain CIII-1
GEN
 are indicated with an 
asterisk, while means statistically significant different from the mutant strain CIII-1
GEN
 ΔrdxA are indicated 
with a hash tag (Turkey’s HSD, ρ < 0.05). 
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8. DISCUSSION  
Zoonotic pathogens exhibit a promiscuous phenotype, as they are able to colonize and cause 
infections in more than one host species. In contrast, some pathogens are host-restricted 
(Thomson, et al., 2008). Although the host-restricted pathogen H. pylori and NPGHS share 
similar evolutionary history and colonize analogous niches, the latter species group also 
contains zoonotic organisms (Haesebrouck, et al., 2009). A detailed comparative genomic 
analysis of human-derived H. heilmannii s.l. with H. pylori offers a opportunity to investigate 
how these similar highly-specialized bacterial species have these different life-styles 
regarding host spectra and to their pathogenicity. However, the fastidious nature of NPGHS 
and the limited number of available human isolates, make it relatively difficult to study the 
molecular mechanisms of the zoonotic transmission of NPGHS so these are still unknown. In 
study I, we provided a detailed comparative genome analysis of the first human-derived H. 
heilmannii s.l. strain H. bizzozeronii CIII-1 and H. pylori. 
 
Our comparative genomic analysis showed that H. bizzozeronii CIII-1 most likely possesses 
all the genes necessary for specialized life in the stomach, but this bacterium differs from the 
human-adapted H. pylori by having wider metabolic flexibility in terms of its energy sources 
and a more intricate electron transport chain. Specifically, our results indicated that the 
central energy metabolism (citric acid cycle) and the respiratory chain in H. bizzozeronii CIII-
1 is more branched and complex compared to those of H. pylori. In addition, H. bizzozeronii 
possesses five times more methyl-accepting chemotaxis proteins than H. pylori (Tomb, et al., 
1997), which indicates an elaborate sensing capability for this species. All these features, 
which we found to be common among the other H. heilmannii s. l., might support the 
capability of these Helicobacter species to manage different ecological niches and would 
explain their ability to transfer between different hosts. Several studies have highlighted the 
fact that those pathogens which show host-restricted phenotypes had lost many common 
functional traits during their evolution compared to their sister species with more 
promiscuous phenotypes (Alsmark, et al., 2004, Thomson, et al., 2008). A similar scenario 
could be also inferred from our present analysis on evolution of the gastric Helicobacter spp. 
A progressive specialization of H. pylori towards its human host has resulted in the loss of 
several branches in the metabolic and respiratory pathways and has also compromised the 
bacterium’s capability to colonize different hosts.  
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Genome plasticity is an important factor for adaption and evolution of H. pylori (Suerbaum & 
Josenhans, 2007). In study I, we showed that H. bizzozeronii possesses several characteristics, 
such as a genomic island, transposable elements, homopolymeric runs, that may facilitate 
genome rearrangement and recombination. In study III, we observed that H. bizzozeronii had 
undergoes extensive genome diversification during one year of colonization, which underlies 
the importance of these features in host jumping and gastric adaptation.  
 
We predicted that 43 genes of H. bizzozeronii could undergo phase variation due to the 
slipped strand mispairing of homopolymeric runs of a single nucleotides. As was observed 
for H. pylori and C. jejuni (Salaun, et al., 2004, Salaun, et al., 2005, Parkhill, et al., 2000),  
these genes may be involved in the modification of either protein or carbohydrate of bacterial 
surface structures such as LPS, which play a role in adaption of the bacterial species to 
different hosts (Jerome, et al., 2011). For example, it has been shown that the C-lectin DC-
SIGN, expressed by dendritic cells, interacts with terminal phase-variable fucosylated LPS of 
H. pylori, which mimics the mammalian Lewis antigen (Bergman, et al., 2004). The 
fucosylated LPS is expressed on the surface of H. pylori cells and it modulates the T-helper 
cell response. In study II, we observed that H. bizzozeronii expressed terminal phase-variable 
sialylated LPS. In particular, the structural analysis of LPS and the functional analysis of the 
ST revealed that sialic acid decorates the LacNAc epitope in the LPS of both canine and 
human-derived H. bizzozeronii strains. The phase variation of this structure is probably due to 
the contingency nature of several glycosyltransferases (such as putative fucosyltransferase 
and galactosyltranferase identified in study I). In addition, the 2-epimerase involved in the 
biosynthesis of sialic acid in some H. bizzozeronii strains undergoes phase variation due to 
the slipped strand mispairing of SSR and may modulate the phase variable expression of 
sialylated LPS. The presence of sialic acids in external glycoconjugates is a common feature 
in mucosal pathogens and has a strong impact on their virulence. For example, the sialylated 
glycoconjugates in C. jejuni that mimic the host neural surface structures and act as ligands 
that hijack host-cell receptors and/or lectins during adhesion and colonization can trigger 
severe sequelae such as Guillain–Barré syndrome (Louwen, et al., 2012). Furthermore, H. 
pylori expresses the sialylated epitopes (sialyl-Fuc-LacNac), which mimic the antigen (sialyl- 
Le
x
) expressed by the human host (Monteiro, et al., 2000). In study II, affinity blotting 
revealed the presence of sialyl-Le
x
 in two H. bizzozeronii strains, which suggests that the 
bacteria are also able to transfer sialic acid to the fucosylated LacNac residue. This transfer 
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may confer an advantage during the adaptation to the human host. The role of the phase-
variable expression of sialic acid on the Helicobacter LPS in the interaction with the host 
needs further investigation. However, our data indicate that the expression of these surface 
glycoconjugates may influence the adaptation of H. bizzozeronii during the host jump from 
dogs to humans.  
 
Phase variation is an important mechanism that is used by bacteria to adapt to different 
environmental conditions (Salaun, et al., 2005). It is frequently associated with the 
phenotypic or antigenic variation of surface structures such as LPS as described above. 
However, it also participates in the modulation of gene expression by on/off switching of 
several systems such as the type III restriction/modification (Srikhanta, et al., 2011). In study 
III, we reported that several genes potentially involved in metabolic and respiratory pathways 
in H. bizzozeronii also undergo phase variation due to the expansion or contraction of SSR. 
We speculated that the on/off switching of these genes, in H. bizzozeronii can increase the 
bacterium’s fitness, for example, in the contet of metronidazole selection. In particular, we 
hypothesized that the contingency nature of the oxygen-insensitive NAD(P)H-nitroreductase 
rdxA is the basis of the acquisition of metronidazole resistance, an antibiotic frequently used 
in the treatment of Helicobacter infection. In study IV, we investigated this hypothesis in 
more detail. We showed that the extension of the simple sequence repeat in the 3 of rdxA, 
which induced the disruption of the conserved region IACLXALGK, was the only mutation 
that we detected in the majority of in vitro spontaneous H. bizzozeronii metronidazole 
resistant mutants. In addition, we observed that H. bizzozeronii ΔrdxA mutant strains had the 
same MIC value for metronidazole that was observed in the spontaneous mutants. These data 
indicate that the disruption of the C-terminal conserved domain in rdxA that results from the 
slipped strand mispairing of a polycytosine is sufficient to produce clinically significant 
resistance to metronidazole in H. bizzozeronii. Several years of investigation have provided 
evidence that the main causes of metronidazole resistance in H. pylori are mutations that alter 
the correct function of the nitroreductases rdxA or frxA (Kaakoush, et al., 2009). However, 
there is no evidence that these genes are contingency loci in this Helicobacter species. 
Therefore, H. bizzozeronii rdxA represents the first example of a contingency gene being 
associated with metronidazole resistance. In study IV, we also observed an increased level of 
susceptibility to metronidazole in a H. bizzozeronii spontaneous resistant mutant that was 
maintained under non-selective conditions after approximately 15 passages. This finding 
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indicated that the resistant phenotype could be reversible. Thus, it is tempting to speculate 
that metronidazole resistance in H. bizzozeronii is a phase-variable phenotype and this is due 
to the contingency nature of rdxA. However, several other unknown mechanisms could also 
lead to metronidazole resistance in H. bizzozeronii, which would overcome the stochastic 
variation. It is worth noting that numerous single nucleotide polymorphisms and insertions or 
deletions were detected in the H. bizzozeronii metronidazole resistant strain compared to its 
isogenic susceptible one in the genome comparison carried out in study III. As these data 
indicate that other mechanisms could play a role in the acquisition of resistance to 
metronidazole by H. bizzozeronii, further studies are needed to elucidate these mechanisms. 
Although phase variation allows the bacterial species to adapt to rapidly changing conditions, 
genetic drift and homologous recombination allow the gradual accumulation of genetic 
variability, which is the basis for the successful colonization of the stomach by Helicobacter 
species. In fact, several studies have revealed that the H. pylori population in an individual 
human host shows extensive diversity by the accumulation of variants within individual 
strains (Morelli, et al., 2010, Kennemann, et al., 2011). The balance between genomic 
integrity and diversification in H. pylori creates a dynamic pool of genetic variants that are 
able to occupy all potential niches in the human stomach (Kang & Blaser, 2006). It has been 
proposed that H. pylori developed this mechanism during its co-evolution with the human 
host (Kang & Blaser, 2006). However, in study III, we observed that H. bizzozeronii 
underwent extreme genomic diversification during only one year of chronic infection of a 
human host. Our data revealed that the enormous genome plasticity also observed for H. 
pylori is not a consequence of co-evolution within a single host but rather is a fundamental 
prerequisite for adaptation to the rapidly changing gastric environment, which is common 
among all gastric Helicobacter species. 
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9. CONCLUSIONS.  
The studies presented in this thesis underline the genetic basis of the zoonotic nature of 
NPGHS infections in humans. In addition, data obtained from this research will be helpful in 
the treatment of NPGHS infections.  
1. A detailed comparative genomic analysis between the human strain H. bizzozeronii CIII-1 
and H. pylori revealed important differences between these two human gastric pathogens. 
H. bizzozeronii was shown to possess all genes necessary for its specialized life in the 
human stomach. However, H. bizzozeronii differs from H. pylori by having a wider 
metabolic flexibility and it also harbours higher numbers of MCPs compared to H. pylori.  
Using our results, we hypothesized that high metabolic flexibility in combination with its 
exceptionally great genome plasticity gives H. bizzozeronii the ability to move through 
several environments and adapt to different hosts. 
 
2. We described the expression and functional characterization of α,2,3-sialyltransferase that 
was obtained from H. bizzozeronii. This enzyme manifested the ability of H. bizzozeronii 
to transfer sialic acid on the lactosamine residue of its LPS. The expression of sialyl-LPS 
may mimic the surface glycans of mammalian cells, which would facilitate the adaptation 
and lead to successful colonisation of H. bizzozeronii in human gastric mucosa during the 
host jump from dogs to humans. 
 
3. We also observed that to colonize the human stomach successfully H. bizzozeronii 
generates remarkable genetic diversity that allows the bacterium to evolve rapidly once a 
selective pressure is applied. Antimicrobial treatment drove the microevolution of H. 
bizzozeronii to select a subpopulation that acted as the founder for the new population. 
These data indicate that high genome plasticity is a fundamental prerequisite of all gastric 
Helicobacter species for the adaptation to the stomach environment.  
 
4. Data obtained in this study indicate that the disruption of the C-ternimal conserved 
domain in rdxA of H. bizzozeronii that was due to the slipped strand mispairing of an 
simple sequence repeat, is sufficient to produce clinically significant resistance to 
metronidazole in this species. The potential contingency nature of H. bizzozeronii rdxA 
should be taken in consideration in selecting metronidazole as a first choice for the 
treatment of H. bizzozeronii associated gastritis. 
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